BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 28222427)

  • 1. Impact of FMR1 Pre-Mutation Status on Blastocyst Development in Patients Undergoing Pre-Implantation Genetic Diagnosis.
    Hutchinson AP; Pereira N; Lilienthal DP; Coveney S; Lekovich JP; Elias RT; Rosenwaks Z
    Gynecol Obstet Invest; 2018; 83(1):23-28. PubMed ID: 28222427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What is the threshold of mature oocytes to obtain at least one healthy transferable cleavage-stage embryo after preimplantation genetic testing for fragile X syndrome?
    Sonigo C; Mayeur A; Sadoun M; Pinto M; Benguigui J; Frydman N; Monnot S; Benachi A; Steffann J; Grynberg M
    Hum Reprod; 2021 Oct; 36(11):3003-3013. PubMed ID: 34568938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are ovarian response and pregnancy rates similar in selected FMR1 premutated and mutated patients undergoing preimplantation genetic testing?
    Ranisavljevic N; Hess M; Castelli C; Willems M; Ferrieres-Hoa A; Girardet A; Anahory T
    J Assist Reprod Genet; 2020 Jul; 37(7):1675-1683. PubMed ID: 32483686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated levels of FMR1 mRNA in granulosa cells are associated with low ovarian reserve in FMR1 premutation carriers.
    Elizur SE; Lebovitz O; Derech-Haim S; Dratviman-Storobinsky O; Feldman B; Dor J; Orvieto R; Cohen Y
    PLoS One; 2014; 9(8):e105121. PubMed ID: 25153074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of CGG repeat number on ovarian response among fragile X premutation carriers undergoing preimplantation genetic diagnosis.
    Bibi G; Malcov M; Yuval Y; Reches A; Ben-Yosef D; Almog B; Amit A; Azem F
    Fertil Steril; 2010 Aug; 94(3):869-74. PubMed ID: 19481741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diminished ovarian reserve is not observed in infertility patients with high normal CGG repeats on the fragile X mental retardation 1 (FMR1) gene.
    Schufreider A; McQueen DB; Lee SM; Allon R; Uhler ML; Davie J; Feinberg EC
    Hum Reprod; 2015 Nov; 30(11):2686-92. PubMed ID: 26345686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Follicular versus luteal phase ovarian stimulation during the same menstrual cycle (DuoStim) in a reduced ovarian reserve population results in a similar euploid blastocyst formation rate: new insight in ovarian reserve exploitation.
    Ubaldi FM; Capalbo A; Vaiarelli A; Cimadomo D; Colamaria S; Alviggi C; Trabucco E; Venturella R; Vajta G; Rienzi L
    Fertil Steril; 2016 Jun; 105(6):1488-1495.e1. PubMed ID: 27020168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preimplantation genetic diagnosis for fragile X syndrome: is there increased transmission of abnormal FMR1 alleles among female heterozygotes?
    Reches A; Malcov M; Ben-Yosef D; Azem F; Amit A; Yaron Y
    Prenat Diagn; 2009 Jan; 29(1):57-61. PubMed ID: 19097038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FMR1 expression in human granulosa cells increases with exon 1 CGG repeat length depending on ovarian reserve.
    Rehnitz J; Alcoba DD; Brum IS; Dietrich JE; Youness B; Hinderhofer K; Messmer B; Freis A; Strowitzki T; Germeyer A
    Reprod Biol Endocrinol; 2018 Jul; 16(1):65. PubMed ID: 29981579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical analysis of preimplantation genetic diagnosis with HLA matching for beta-thalassemia].
    Liu XY; Wang J; Zeng YH; Ding CH; Shen XT; Zhou W; Li R; Zhou CQ; Xu YW
    Zhonghua Fu Chan Ke Za Zhi; 2016 Jul; 51(7):491-7. PubMed ID: 27465867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FMR1 CGG repeat expansion mutation detection and linked haplotype analysis for reliable and accurate preimplantation genetic diagnosis of fragile X syndrome.
    Rajan-Babu IS; Lian M; Cheah FSH; Chen M; Tan ASC; Prasath EB; Loh SF; Chong SS
    Expert Rev Mol Med; 2017 Jul; 19():e10. PubMed ID: 28720156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ranking and selection of MII oocytes in human ICSI cycles using gene expression levels from associated cumulus cells.
    Ekart J; McNatty K; Hutton J; Pitman J
    Hum Reprod; 2013 Nov; 28(11):2930-42. PubMed ID: 24041818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pre-in vitro maturation medium containing cumulus oocyte complex ligand-receptor signaling molecules maintains meiotic arrest, supports the cumulus oocyte complex and improves oocyte developmental competence.
    Santiquet NW; Greene AF; Becker J; Barfield JP; Schoolcraft WB; Krisher RL
    Mol Hum Reprod; 2017 Sep; 23(9):594-606. PubMed ID: 28586460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between follicular volume and oocyte competence, blastocyst development and live-birth rate: optimal follicle size for oocyte retrieval.
    Wirleitner B; Okhowat J; Vištejnová L; Králíčková M; Karlíková M; Vanderzwalmen P; Ectors F; Hradecký L; Schuff M; Murtinger M
    Ultrasound Obstet Gynecol; 2018 Jan; 51(1):118-125. PubMed ID: 29134715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of fragile X pre-mutation carriers in the Chinese obstetric population using a robust FMR1 polymerase chain reaction assay: implications for screening and prenatal diagnosis.
    Cheng YK; Lin CS; Kwok YK; Chan YM; Lau TK; Leung TY; Choy KW
    Hong Kong Med J; 2017 Apr; 23(2):110-6. PubMed ID: 28253484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of skewed X-chromosome inactivation with FMR1 CGG repeat length and anti-Mullerian hormone levels: a cohort study.
    Barad DH; Darmon S; Weghofer A; Latham GJ; Filipovic-Sadic ; Wang Q; Kushnir VA; Albertini DF; Gleicher N
    Reprod Biol Endocrinol; 2017 Apr; 15(1):34. PubMed ID: 28454580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fertilization, embryo development, and clinical outcome of immature oocytes from stimulated intracytoplasmic sperm injection cycles.
    Shu Y; Gebhardt J; Watt J; Lyon J; Dasig D; Behr B
    Fertil Steril; 2007 May; 87(5):1022-7. PubMed ID: 17261289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of fragile X premutation carrier status on embryo morphokinetic development.
    Shulman Y; Kalma Y; Malcov M; Kopel R; Fouks Y; Azem F; Almog B; Cohen Y
    Reprod Biomed Online; 2022 Nov; 45(5):884-889. PubMed ID: 36028392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BRCA1 mutation carriers have a lower number of mature oocytes after ovarian stimulation for IVF/PGD.
    Derks-Smeets IAP; van Tilborg TC; van Montfoort A; Smits L; Torrance HL; Meijer-Hoogeveen M; Broekmans F; Dreesen JCFM; Paulussen ADC; Tjan-Heijnen VCG; Homminga I; van den Berg MMJ; Ausems MGEM; de Rycke M; de Die-Smulders CEM; Verpoest W; van Golde R
    J Assist Reprod Genet; 2017 Nov; 34(11):1475-1482. PubMed ID: 28831696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intermediate and normal sized CGG repeat on the FMR1 gene does not negatively affect donor ovarian response.
    Lledo B; Guerrero J; Ortiz JA; Morales R; Ten J; Llacer J; Gimenez J; Bernabeu R
    Hum Reprod; 2012 Feb; 27(2):609-14. PubMed ID: 22157911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.